LakeShore Biopharma Co Other Current Liabilities

As of the most recent data (March 2025), YS shows a other current liabilities of $380M. That compares with $410M in the prior-year period — down 7.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, YS's other current liabilities is now $380M (was $410M) — a 7.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LakeShore Biopharma Co is outperforming or lagging.

Tracking YS's other current liabilities over time shows whether LakeShore Biopharma Co is scaling, shrinking, or reshaping that part of the business. The current reading is $380M That compares with $410M in the prior-year period — down 7.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has LakeShore Biopharma Co's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $380M) with ownership activity and broader fundamentals.